Caris Life Sciences (CAI) Operating Margin (2024 - 2026)

Caris Life Sciences' Operating Margin history runs 3 years deep, the most recent figure standing at 2.44% for Q1 2026.

• In Q1 2026, Operating Margin rose 5037.0% year-over-year to 2.44%; the TTM figure through Mar 2026 stood at 11.94% (up 6119.0% YoY), while the FY2025 annual figure was 5.56%, up 6792.0% from the prior year.
• Operating Margin was 2.44% for Q1 2026 at Caris Life Sciences, down from 30.19% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 30.19% in Q4 2025 to a low of 66.98% in Q2 2024.
• Historically, Operating Margin has averaged 20.69% across 3 years, with a median of 19.22% in 2024.
• The sharpest annual moves came in 2025 and 2026: Operating Margin surged 7493 bps in 2025, then soared 5037 bps in 2026.
• A 3-year view of Operating Margin shows it stood at 28.52% in 2024, then soared by 206 bps to 30.19% in 2025, then sank by 92 bps to 2.44% in 2026.
• The last three Operating Margin figures came in at 2.44% (Q1 2026), 30.19% (Q4 2025), and 15.05% (Q3 2025), per Business Quant data.